TriSalus Life Sciences TLSI
NASDAQ TLSI
$2.27 -0.03 (-1.30%)
As of: Nov 12, 2026 · 1:42 PM EST

TriSalus Life Sciences (TLSI) Return on Invested Capital [ROIC] (2025 - 2026)

Updated

TriSalus Life Sciences' Return on Invested Capital [ROIC] was -71.37% in Q2 2026, up 537.24 percentage points from -608.61% a year earlier and up 53.01 percentage points from the prior quarter.

Analysis

TriSalus Life Sciences (TLSI) Return on Invested Capital [ROIC] (2025 - 2026) Analysis & Trends

From Q2 2025 onward, TriSalus Life Sciences has reported Return on Invested Capital [ROIC] for 5 quarters.

  • Per Business Quant data, TLSI's Return on Invested Capital [ROIC] in the three quarters before Q2 2026 was -124.37% (Q1 2026), -1031.62% (Q4 2025) and -330.92% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 8.02%
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 5.70%
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 5.83%
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn -
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 11.69%
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn 9.95%
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 9.94%
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn 8.68%
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 4.29%
10 TriSalus Life Sciences 26.68 Mn -137.66 Mn 11.10 Mn -80.38%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -80.38%
Jun 30, 2026 -71.37%
Mar 31, 2026 -124.37%
Dec 31, 2025 -1,031.62%
Sep 30, 2025 -330.92%
Jun 30, 2025 -608.61%
API Access

TriSalus Life Sciences Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=TLSI&period=max&api_key=YOUR_API_KEY